Ocular Therapeutix Hydrogel Technology


Ocular Therapeutix’s proprietary hydrogel technology is a two-part synthetic liquid system that is mixed just prior to application. When the solutions are mixed, the material “crosslinks” to form a hydrogel that is soft, lubricious and flexible. The hydrogel contains linkages which gradually hydrolyze in the presence of water at a predetermined rate, gradually sloughing off in the patients tears. The hydrogel is composed substantially of water and polyethylene glycol (PEG), widely considered an inert and biocompatible material. Ocular Therapeutix’s hydrogel technology is the subject of several issued patents.

PEG-based materials are used in a broad number of medical products including drugs, injectables, and implants. As a result, PEG-based materials have undergone extensive biocompatibility and safety testing and enjoy broad market acceptance. The synthetic nature of these materials eliminates the risks or complications associated with medical technologies based on biological components.



To learn more about other applications using Ocular Therapeutix’s hydrogel technology, click here.